Clinical Research Ethics Committee
This committee reviews applications involving cancer clinical research for both multi-centre and, where required, single site cancer research.
This may include cancer clinical trials
involving:
- prevention
- intervention
- surgery
- diagnosis
|
- therapy
- devices
- procedures.
|
Submitting Proposals
Application forms are available via Online Forms, the national
system that enables users to complete their applications for
research electronically.
National Ethics
Application Form (NEAF)
For information on the required documentation for submissions to
the Clinical Research Ethics Committee please refer to the
Submission Checklist. Please include a copy of this
checklist with your application.
Submission Checklist
- Applicants must email a copy of all documentation to: ethics@cancerinstitute.org.au
- Applicants are to send, in hard copy, one (1) copy of all
documentation (with original signatures), and four (4) copies to:
- Via Post:
Ethics Coordinator
Cancer Institute NSW
PO Box 41
Alexandria NSW 1435
- In Person:
Ethics Coordinator
Cancer Institute NSW
Australian Technology Park
Level 9, 8 Central Avenue
Eveleigh, NSW 2015
Please note: applications will not
progress to a Committee review if a soft copy (via email) is not
provided with the required number of hard copies.
Uncollated documents will be returned to
applicants.
2012 meeting dates
The Cancer Institute NSW Clinical Research Ethics Committee
meets on a monthly basis. Submission closing dates are 11 working
days prior to the next meeting.
| Meeting Date |
Submission Closing Date |
| 28th February |
13th February |
| 27th March |
12th March |
| 24th April |
10th April |
| 29th May |
14th May |
| 26th June |
11th June |
| 31st July |
16th July |
| 28th August |
13th August |
| 25th September |
10th September |
| 30th October |
15th October |
| 27th November |
12th November |
| 18th December |
3rd December |
Submitting indemnity
The Medicines Australia Form of Indemnity for
clinical trials has been developed for use in Australia. It is the
basis for agreements between commercial companies sponsoring
clinical studies and the institution that hosts the study to be
conducted. All companies must use this Form of Indemnity.
There are two versions:
Form of Indemnity - Standard
For use where the Indemnified Party is providing premises for
the conduct of the Study and HREC Review, or is providing premises
only.
Form of Indemnity - Standard
Form of Indemnity - HREC Review Only
For use where the Indemnified Party is providing HREC review
ONLY of the study.
Form of Indemnity - HREC Review Only
Guidance on submitting a form of indemnity
The Institute's Clinical Research Ethics Committee provides
review only of a clinical trial. To assist with completion of
the Form of Indemnity, please review
these guidelines.
Committee members
The current members of the Clinical Research Ethics Committee
include experts in research and clinical care, lay members and
religious representatives.
The Cancer Institute NSW Clinical Research Ethics Committee has
been constituted in accordance with the National Health and Medical
Research Council's National
Statement on Ethical Conduct in Human Research (2007).
| Name |
NHMRC Category |
| A/Prof Winston Liauw (Chair) |
Chairperson |
| Dr Meera Agar (Deputy Chair) |
Research Experience |
| Dr Wendy Hague |
Research Experience |
| Prof Michael Barton |
Research Experience |
| Ms Antoinette Fontela |
Professional Care |
| Prof Neil Merrett |
Professional Care |
| Dr Stephen Goodall |
Professional Care |
| Ms Patricia Baille |
Lay Member |
| Ms Kristin Savell |
Legal Member |
| Ms Yvonne Grant |
Legal Member |
| Dr Hazel Elliot |
Religious Member |
Top of page
